Lymphocyte Disorder T
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes (NCT06390748) | Lin Chen | 2021-01-01 |
Track Lymphocyte Disorder T automatically
Every clearance here is in the API, with alerts when new ones post.